Global Market for Anti-obesity Drugs

Report Code: PHM281A

Publish Date: Dec 2023

Publisher: BCC Publishing

Category: Pharmaceuticals

Download Report Overview

Single User License: $3500

Member Price: FREE

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

This report provides an overview of the global market on anti-obesity drugs and an analysis of global market trends, using 2022 as the base year and forecasting 2023 through 2028 with a compound annual growth rate (CAGR) projection. The report details the anti-obesity drugs market based on drug type, distribution channel, and region.

Report Includes

  • An overview of the current and future global markets for anti-obesity drugs
  • Analyses of the global market trends, with historical market revenue data (sales figures) from 2021 to 2022, estimates for 2023, and projections of compound annual growth rates (CAGRs) through 2028
  • Estimate of the actual market size and revenue forecast for the global anti-obesity drugs market, and corresponding market share analysis based on drug type, distribution channel, and region
  • Overview of ESG outlook with emphasis on sustainability trends and factors on anti-obesity drugs market
  • Identification of the major vendors in the global market for anti-obesity drugs, along with an analysis of the structure of this industry, including company market shares, M&A deals and venture fundings
  • Profiles of the leading global players

Report Scope

The report’s scope includes an overview of the global market for anti-obesity drugs and an analysis of global market trends, using 2022 as the base year and forecasting 2023 through 2028 with a compound annual growth rate (CAGR) projection.

The report analyzes anti-obesity drugs by drug types, assesses distribution channels, and provides an overview regarding product pipeline of major players in market. Leading market players’ profiles, marketed products, pipeline products, and recent market activities are provided. The report details market for anti-obesity drugs based on drug type, distribution channel, and region. Based on drug type, the market is segmented into prescription drugs, and over-the-counter (OTC) drugs. The market is categorized into hospital pharmacies, retail pharmacies, and online pharmacies on the basis of distribution channel. Regional analysis includes North America (U.S., Canada, Mexico), Europe (U.K., Germany, France, Spain, Italy, Rest of Europe), Asia-Pacific (China, India, Japan, and Rest of Asia-Pacific), and the Rest of the world (South America, and the Middle East and Africa).

Report Synopsis

Report Metrics Details
Base year considered 2022
Forecast period considered 2023-2028
Base year market size 2023-2028
Market size forecast $11.3 billion
Growth rate CAGR of 28.9% for the forecast period of 2023-2028
Units considered $ Millions
Segments covered Drug Type, Distribution Channel, and Region
Regions covered North America, Europe, Asia-Pacific, and Rest of the World (RoW)
Countries covered U.S., Mexico, Canada, France, Germany, U.K., Italy, Spain, China, India, Japan, Middle East, Africa, and South America
Key Market Drivers
  • Rising prevalence of obesity and associated health problems.
  • Increasing awareness regarding health-risks associated with obesity.
  • Growing pharmaceutical research and development spending on developing anti-obesity drugs.
Companies studied
ALTIMMUNE INC.BOEHRINGER INGELHEIM INTERNATIONAL GMBH
CURRAX PHARMACEUTICALS LLCLILLY
F. HOFFMANN-LA ROCHE LTD.GSK PLC.
NOVO NORDISK A/SPFIZER INC.
RHYTHM PHARMACEUTICALS, INC.VIVUS INC.
Need a custom data table, graph, region, segment, companies or complete report? CUSTOMIZE NOW

Frequently Asked Questions (FAQs)

The global anti-obesity drugs market was valued at an estimated $3.2 billion in 2023 and is projected to reach $11.3 billion by 2028, at an estimated CAGR of 28.9% during the forecast period of 2023 to 2028.
  • Rising prevalence of obesity and associated health problems.
  • Increasing awareness regarding health-risks associated with obesity.
  • Growing pharmaceutical research and development spending on developing anti-obesity drugs.
The report will provide information on anti-obesity drugs along with their growth projections in the coming years. Recent developments of companies operating in this market space have been covered. Information about product pipelines, competitive intelligence, and patents will help the intended audience formulate investment plans and business strategies. The report also identifies promising and emerging countries where the established players can plausibly expand their business.
The prescription drugs segment currently dominates the overall anti-obesity drugs market and will continue to do so by 2028.
North America holds the highest share in the market.

Analyst Credentials

BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.

Let us assist you! Our analysts are ready to tailor this report to your specific need. REACH OUT TO US TODAY

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: Global Market for Anti-obesity Drugs67Free

Related Reports

Peptide Synthesis: Global Markets

Published - May 2024 | Publisher - Partha Sarathi Das | Code - BIO252A

The global market for peptide synthesis is expected to grow from $90.1 billion in 2023 and projected to reach $157.5 billion by the end of 2028, at a compound annual growth rate (CAGR) of 11.8% during the forecast period of 2023 to 2028.

Weight Management Products, Fitness Equipment, and Services Market

Published - Aug 2023 | Publisher - BCC Publishing | Code - HLC253B

The global market for weight management products, fitness equipment, and services is estimated to increase from $278.5 billion in 2023 to reach $424.8 billion by 2028, at a compound annual growth rate (CAGR) of 8.8% from 2023 through 2028.

Weight Loss and Weight Management Diet Market

Published - Aug 2023 | Publisher - BCC Publishing | Code - HLC291A

This report provides a comparative study of different types of diets with emphasis on weight management. It offers an understanding of the role of genes, guts, and dietary nutrition in weight management.

Bariatric Surgery: Global Markets for Services and Devices

Published - May 2021 | Publisher - BCC Publishing | Code - HLC153C

The global market for bariatric devices should increase from $1.5 billion in 2020 to nearly $2.2 billion by 2025 at a compound annual growth rate (CAGR) of 7.5% during the forecast period, 2020-2025.

Recent Reports

Gastrointestinal Therapeutics and Diagnostics: Technologies and Global Markets

Published - Apr 2024 | Publisher - BCC Publishing | Code - PHM046D

The global market for gastrointestinal (GI) therapeutics and diagnostics is expected to grow from $86.0 billion in 2023 and projected to reach $122.5 billion by the end of 2028, at a compound annual growth rate (CAGR) of 7.3% during the forecast period of 2023 to 2028.

Global Markets and Technologies for Advanced Drug Delivery Systems

Published - Mar 2024 | Publisher - BCC Publishing | Code - PHM006N

The global market for advanced drug delivery systems is expected to increase from $262.6 billion in 2023 to $359.1 billion by the end of 2028, with a compound annual growth rate (CAGR) of 6.5% during the forecast period of 2023-2028.

Prevention and Treatment of Prostate Cancer: Technologies and Global Markets

Published - Feb 2024 | Publisher - BCC Publishing | Code - PHM113C

The global market for prostate cancer care is expected to grow from $37.9 billion in 2023 to $56.4 billion by the end of 2028, at a compound annual growth rate (CAGR) of 8.3% from 2023 through 2028.

Global Markets for Vaccine Technologies

Published - Feb 2024 | Publisher - BCC Publishing | Code - PHM014K

The global market for vaccine technologies is expected to grow from $45.0 billion in 2023 to $65.3 billion by the end of 2028, at a compound annual growth rate (CAGR) of 7.8% from 2023 to 2028.

Chagas Disease: American trypanosomiasis Market

Published - Feb 2024 | Publisher - BCC Publishing | Code - PHM282A

The report provides detailed coverage of the Chagas Disease market. It analyzes the market trends and epidemiology of CD, and the regional markets of CD. It highlights the current market for CD and gives a detailed analysis of the competitive environment. The report depicts the complete scenario of Chagas Disease, types of parasites that cause human African trypanosomiasis (HAT) and its presence in various regions of the world.

Top Trending Reports

Cell and Gene Therapy Tools, and Reagents: Global Markets

Published - Nov 2022 | Publisher - BCC Publishing | Code - BIO208B

The global market for cell and gene therapy tools and reagents is estimated to grow from $8.3 billion in 2022 to $13.7 billion in 2027, with a compound annual growth rate (CAGR) of 10.6% for the period of 2022-2027.

ESG Trends in Chemical Industry

Published - Dec 2022 | Publisher - BCC Publishing | Code - ENV056A

This report focuses on the ESG trends in the chemical industry and evaluates the ESG implementation including current and future potential. The report utilizes various databases, including sustainability reports, annual reports, and other indicators used to develop the current market. The study provides detailed information on the main factors influencing ESG growth in the chemical industry. It enables the reader to understand the industry in general while also providing insight into the inter-relationship between ESG and the sustainable chemical industry. The report describes market growth, developing trends, industry leaders, and applications of ESG implementation in the  chemical industry.

Digital Pathology: Technologies and Global Markets

Published - Dec 2022 | Publisher - BCC Publishing | Code - HLC161D

The global digital pathology market is estimated to increase from $5.9 billion in 2022 to reach $10.7 billion by 2027, at a compound annual growth rate (CAGR) of 12.5% from 2022 through 2027.

Non-Fungible Tokens (NFT): Global Market

Published - Nov 2022 | Publisher - BCC Publishing | Code - IFT248A

The global NFTs market should reach $37.6 billion by 2022 and $125.6 billion by 2027, with a compound annual growth rate (CAGR) of 27.3% during the forecast period of 2022-2027.

AI in Mental Health: Global Market Outlook

Published - Dec 2022 | Publisher - BCC Publishing | Code - IFT263A

The report provides an overview of the global AI in mental health market and analyzes market trends. Using 2021 as the base year, the report provides estimated market data for the forecast period, 2022-2027. Revenue forecasts for this period are segmented based on organization size, component, provider, type, industry, and geography. It also highlights major trends and challenges that affect the market and the vendor landscape. 

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
Global Market for Anti-obesity Drugs
Sample Report